Alkylating agent methyl methanesulfonate (MMS) induces a wave of global protein hyperacetylation: Implications in cancer cell death

Biochemical and Biophysical Research Communications

Volumn 360, Issue 2, 2007, Pages 483-489

  Lee, Min Young ^a   Kim, Myoung Ae ^a   Kim, Hyun Ju ^a   Bae, Yoe Sik ^a   Park, Joo In ^a   Kwak, Jong Young ^a   Chung, Jay H ^b   Yun, Jeanho ^a  

^a Dong A University   (South Korea)

^b NIH/NHLBI/LBG   (United States)

Author keywords

Cell death; HDAC inhibitors; Methyl methanesulfonate; Protein acetylation

Indexed keywords

ACETYLCYSTEINE; CYTOPLASM PROTEIN; GLUTATHIONE; HISTONE DEACETYLASE INHIBITOR; MESYLIC ACID METHYL ESTER; NUCLEAR PROTEIN;

ACETYLATION; ARTICLE; CANCER CELL; CANCER SUSCEPTIBILITY; CELL DEATH; CONTROLLED STUDY; CORRELATION ANALYSIS; EMBRYO; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN MODIFICATION; SIGNAL TRANSDUCTION;

ACETYLATION; ANTINEOPLASTIC AGENTS, ALKYLATING; APOPTOSIS; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; METHYL METHANESULFONATE; NEOPLASM PROTEINS; NEOPLASMS;

EID: 34447096400     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.06.084     Document Type: Article

References (23)

1. Chen H., Tini M., and Evans R.M. HATs on and beyond chromatin. Curr. Opin. Cell Biol. 13 (2001) 218-224
2. Sterner D.E., and Berger S.L. Acetylation of histones and transcription-related factors. Microbiol. Mol. Biol. Rev. 64 (2000) 435-459
3. Brunet A., et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303 (2004) 2011-2015
4. Blander G., Zalle N., Daniely Y., Taplick J., Gray M.D., and Oren M. DNA damage-induced translocation of the Werner helicase is regulated by acetylation. J. Biol. Chem. 277 (2002) 50934-50940
5. Cohen H.Y., et al. Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis. Mol. Cell 13 (2004) 627-638
6. Okumura K., Mendoza M., Bachoo R.M., DePinho R.A., Cavenee W.K., and Furnari F.B. PCAF modulates PTEN activity. J. Biol. Chem. 281 (2006) 26562-26568
7. Martinez-Balbas M.A., Bauer U.M., Nielsen S.J., Brehm A., and Kouzarides T. Regulation of E2F1 activity by acetylation. EMBO J. 19 (2000) 662-671
8. Kouzarides T. Acetylation: a regulatory modification to rival phosphorylation?. EMBO J. 19 (2000) 1176-1179
9. Wyatt M.D., and Pittman D.L. Methylating agents and DNA repair responses: methylated bases and sources of strand breaks. Chem. Res. Toxicol. 19 (2006) 1580-1594
10. Beranek D.T. Distribution of methyl and ethyl adducts following alkylation with monofunctional alkylating agents. Mutat. Res. 231 (1990) 11-30
11. Kim M.A., et al. Identification of novel substrates for human checkpoint kinase Chk1 and Chk2 through genome-wide screening using a consensus Chk phosphorylation motif. Exp. Mol. Med. 39 (2007) 205-212
12. Kurtev V., Margueron R., Kroboth K., Ogris E., Cavailles V., and Seiser C. Transcriptional regulation by the repressor of estrogen receptor activity via recruitment of histone deacetylases. J. Biol. Chem. 279 (2004) 24834-24843
13. Bae Y.S., Bae H., Kim Y., Lee T.G., Suh P.G., and Ryu S.H. Identification of novel chemoattractant peptides for human leukocytes. Blood 97 (2001) 2854-2862
14. Kastan M.B., and Bartek J. Cell-cycle checkpoints and cancer. Nature 432 (2004) 316-323
15. Wilhelm D., Bender K., Knebel A., and Angel P. The level of intracellular glutathione is a key regulator for the induction of stress-activated signal transduction pathways including Jun N-terminal protein kinases and p38 kinase by alkylating agents. Mol. Cell Biol. 17 (1997) 4792-4800
16. Marks P., Rifkind R.A., Richon V.M., Breslow R., Miller T., and Kelly W.K. Histone deacetylases and cancer: causes and therapies. Nat. Rev. Cancer 1 (2001) 194-202
17. Hunter T. The Croonian Lecture 1997. The phosphorylation of proteins on tyrosine: its role in cell growth and disease. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 353 (1998) 583-605
18. Chen H., Lin R.J., Xie W., Wilpitz D., and Evans R.M. Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase. Cell 98 (1999) 675-686
19. Ait-Si-Ali S., et al. Histone acetyltransferase activity of CBP is controlled by cycle-dependent kinases and oncoprotein E1A. Nature 396 (1998) 184-186
20. Barlev N.A., Poltoratsky V., Owen-Hughes T., Ying C., Liu L., Workman J.L., and Berger S.L. Repression of GCN5 histone acetyltransferase activity via bromodomain-mediated binding and phosphorylation by the Ku-DNA-dependent protein kinase complex. Mol. Cell Biol. 18 (1998) 1349-1358
21. Liu L., Scolnick D.M., Trievel R.C., Zhang H.B., Marmorstein R., Halazonetis T.D., and Berger S.L. p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Mol. Cell Biol. 19 (1999) 1202-1209
22. Markham D., Munro S., Soloway J., O'Connor D.P., and La Thangue N.B. DNA-damage-responsive acetylation of pRb regulates binding to E2F-1. EMBO Rep. 7 (2006) 192-198
23. Cress W.D., and Seto E. Histone deacetylases, transcriptional control, and cancer. J. Cell Physiol. 184 (2000) 1-16